Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy

Immune checkpoint inhibitor (ICI)-induced liver injury (LI) is a common adverse event, but the clinical characteristics based on the classification of hepatocellular injury and cholestatic types are not fully evaluated. This study aims to analyze risk factors and histological findings in relation to...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Miki Kawano, Yoshihiko Yano, Atsushi Yamamoto, Eiichiro Yasutomi, Yuta Inoue, Jun Kitadai, Ryutaro Yoshida, Takanori Matsuura, Yuuki Shiomi, Yoshihide Ueda, Yuzo Kodama
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-04-01
coleção:	Diagnostics
Assuntos:	immune checkpoint inhibitor liver injury DILI histology
Acesso em linha:	https://www.mdpi.com/2075-4418/14/8/815
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!